NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » NeurodigitX Launches First Digital Inflammatory Biomarker Platform to Support COVID-19 Pandemic Exit Strategy » laboratory-3827736_640(1)

NeurodigitX Launches First Digital Inflammatory Biomarker Platform to Support COVID-19 Pandemic Exit Strategy

NS Medical Devices is using cookies

NeurodigitX launches first digital inflammatory biomarker platform. (Credit: Belova59 from Pixabay.)

Related Article

Five medical devices used for the early detection of heart disease

RECOMMENDED COMPANIES

MOST READ

Who ordered the liver? A 3D-printed replica could make difficult procedures easier by allowing surgeons to rehearse before theatre

Five medical devices used for the early detection of heart disease

Top 10 companies providing electronic manufacturing services to the medical device industry

Boston Scientific launches SpaceOAR Vue Hydrogel in Europe for safer prostate radiotherapy

Next generation hydrogels could be tougher after new breakthrough by Tokyo scientists

Recommended Whitepaper